Ataeinia Bahar, Loberg Christina, Kravets Hanna, Beheshti Mohsen, von Mallek Dirk, Mottaghy Felix M, Heinzel Alexander
Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany.
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
EXCLI J. 2019 May 21;18:273-276. doi: 10.17179/excli2019-1220. eCollection 2019.
We present the case of a 77 year old male patient with metastatic pancreatic neuroendocrine tumor (NET). The patient was initially treated by extensive surgical resection that however, led to severe complications with delayed recovery. During follow-up, a number of new liver metastases were detected, one of which was in segment I with impending compression of the inferior vena cava. Due to age and general condition of the patient, instead of further surgical treatment, the patient received four cycles of Lu-DOTATOC resulting in an overall partial response with successful tumor reduction in liver segment I, resolving an impending compression of vena cava.
我们报告一例77岁男性转移性胰腺神经内分泌肿瘤（NET）患者的病例。该患者最初接受了广泛的手术切除，但术后出现严重并发症，恢复延迟。在随访期间，发现了多处新的肝转移灶，其中一个位于Ⅰ段，即将压迫下腔静脉。鉴于患者的年龄和一般状况，患者未接受进一步的手术治疗，而是接受了四个周期的镥-奥曲肽治疗，总体上部分缓解，成功缩小了肝Ⅰ段的肿瘤，解除了即将发生的腔静脉压迫。
